SCHEMBL8556765

SCHEMBL8556765

CCCCCNC(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.68
CYP2C9 P11712 1/20 0.68
HPGD P15428 1/20 0.68
EPHX1 P07099 3/20 0.64
ALDH1A1 P00352 1/20 0.64
HTT P42858 1/20 0.64
POLB P06746 1/20 0.62
CFD P00746 1/20 0.60
PTPN1 P18031 1/20 0.57
USP2 O75604 1/20 0.56
PLK1 P53350 4/20 0.55
PLK3 Q9H4B4 3/20 0.55
EPHX2 P34913 2/20 0.54
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10922018 0.89 L3MBTL1 (0.69) L3MBTL1CYP2C9HPGDEPHX1ALDH1A1
SCHEMBL6442708 0.86 EPHX1 (0.73) L3MBTL1EPHX1ALDH1A1HTTPOLB
SCHEMBL9119762 0.86 EPHX1 (0.58) L3MBTL1CYP2C9HPGDEPHX1ALDH1A1
SCHEMBL29098671 0.85 GAA (0.70) L3MBTL1EPHX1ALDH1A1HTTPOLB
SCHEMBL10362736 0.85 GAA (0.70) L3MBTL1EPHX1ALDH1A1HTTPOLB
SCHEMBL10363617 0.85 GAA (0.70) L3MBTL1EPHX1ALDH1A1HTTPOLB
SCHEMBL13614088 0.83 GAA (0.71) L3MBTL1CYP2C9HPGDALDH1A1POLB
SCHEMBL11110593 0.82 POLB (0.81) L3MBTL1CYP2C9HPGDEPHX1ALDH1A1
SCHEMBL415266 0.82 L3MBTL1 (0.60) L3MBTL1CYP2C9HPGDEPHX1ALDH1A1
SCHEMBL466141 0.81 PLK1 (0.63) L3MBTL1CYP2C9HPGDALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0653423-B1 Process for the preparation of substituted quinazoline-2,4-diones CLARIANT GMBH (DE) 1999-06-16 EP claimed
EP-0653423-A1 Process for the preparation of substituted quinazoline-2,4-diones HOECHST AKTIENGESELLSCHAFT (DE) 1995-05-17 EP disclosed